IIDQ antibodies with liver transplant after liver transplant after liver transplant after liver tran

An international medical study has produced new findings that have important reference value for disease prevention. The main purpose of this study is to assess the presence of pre-prepared HLA antibodies (DSAs) after liver transplantation and to significantly correlate the survival rate of liver transplantation after liver transplantation. In the study, we analyzed the presence of pre-prepared HLA antibodies using single-antigen bead assay and virtual cross-sectional distribution of HLA antibodies (DSAs) unknown to clinicians.

By analyzing the distribution of pre-prepared HLA antibodies (DSAs), we assessed the presence of pre-prepared HLA antibodies (DSAs) after liver transplantation and significantly correlated with liver transplant survival rates after liver transplantation. During the 2-year follow-up, Type II DSA was associated with 13 percent of 832 patients. Type II DSA was associated with 16 percent of 131 patients.

Class II DQ subtype was the only independent predictor of graft loss (adjusted HR 2. 0, 95% CI: 1. 1-3.

6, P = 0. 02) with a 2-year graft loss rate of 23% (95% CI: 15-34%) compared to 10% (95% CI: 8-12%) without class II DQ and 7% (95% CI: 2-20%) for DR-specific antibodies (log-rank P = 0. 002).

Mean fluorescence intensity was not independently associated with graft loss after adjustment for DQ sta It should be noted that the above content is based on international public research findings and is for reference in HealthCop and does not constitute a clinical recommendation. If you have any health questions, please consult professional medical personnel.